Liposome-based vaccines for minimally or noninvasive administration: an update on current advancements.

liposome-based vaccines administered through minimally or noninvasive routes are expected to improve efficacy and complacency of vaccination programs. However, the translation from lab-scale production to large-scale production and collaborations with hospitals, research centers and companies are needed to allow new products to enter the market and improve the vaccination programmes in the future.